GREEN CROSS WELLBEING CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,100 KRW | -0.98% |
|
+2.02% | +24.23% |
| 2022 | GREEN CROSS WellBeing Corporation(KOSDAQ:A234690) dropped from S&P Global BMI Index | CI |
| 2020 | GREEN CROSS WellBeing Corporation(KOSDAQ:A234690) added to S&P Global BMI Index | CI |
| Sales 2022 | 110B 79.77M 6.66B | Sales 2023 | 121B 87.63M 7.31B | Capitalization | 144B 105M 8.75B |
|---|---|---|---|---|---|
| Net income 2022 | 8B 5.82M 485M | Net income 2023 | 6.75B 4.91M 409M | EV / Sales 2022 | 1.59 x |
| Net Debt 2022 | 28.89B 21M 1.75B | Net Debt 2023 | 34.1B 24.79M 2.07B | EV / Sales 2023 | 1.48 x |
| P/E ratio 2022 |
18.3
x | P/E ratio 2023 |
21.4
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 46.72% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.98% | ||
| 1 week | +2.02% | ||
| Current month | -2.04% | ||
| 1 month | -3.44% | ||
| 3 months | -0.98% | ||
| 6 months | +66.67% | ||
| Current year | +24.23% |
1 week
10 030.00
10 750.00
1 month
8 770.0010 770.00
Current year
7 620.0012 680.00
1 year
6 010.0012 680.00
3 years
5 910.0014 100.00
5 years
5 060.0018 850.00
10 years
5 060.0018 850.00
| Managers | Title | Age | Since |
|---|---|---|---|
Sang-Hyeon Kim
CEO | Chief Executive Officer | 58 | - |
Hye-Jung Han
CTO | Chief Tech/Sci/R&D Officer | 54 | - |
Seong-Tae Ha
AUD | Comptroller/Controller/Auditor | 61 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hong-Seok Im
BRD | Director/Board Member | 58 | - |
Myeong-Cheol Kim
BRD | Director/Board Member | 61 | - |
Sang-Hyeon Kim
CEO | Chief Executive Officer | 58 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/24/29 | 10,180 | +0.79% | 77,281 |
| 26/24/26 | 10,100 | -0.98% | 96,374 |
| 25/24/25 | 10,200 | -4.05% | 115,744 |
| 24/24/24 | 10,630 | +3.40% | 71,713 |
| 23/24/23 | 10,280 | +0.78% | 92,846 |
End-of-day quote Korea S.E., April 26, 2024
More quotes
GREEN CROSS WellBeing Corporation is a Korea-based company principally engaged in manufacture and distribution of Laennec Inj. and other injections. The Company mainly manufactures and sells injections and health functional foods. The Companyâs products include vitamin injections such as Megagreen and Fursultamine, as well as health functional foods such as probiotics and red ginsengs. The Company sells health functional foods used for hospitals under the brand name of Dr.PNT. In addition, the Company also sells cosmetics.
Sector
Pharmaceuticals
Calendar
13/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +24.23% | 130M | |
| -4.06% | 86.13B | |
| +1.32% | 39.82B | |
| +56.59% | 25.23B | |
| -14.41% | 15.36B | |
| -8.82% | 11.95B | |
| -15.77% | 11.6B | |
| -43.00% | 11.51B | |
| +6.14% | 8.71B | |
| -7.02% | 8.12B |
- Stock Market
- Equities
- A234690 Stock
